MST1 and head and neck cancer: In head and neck cancer, reduced MST1/2 activity is closely associated with sustained activation of YAP/TAZ, which in turn drives cell proliferation and invasion (Shin and Kim, 2020; Santos-de-frutos et al., 2019; Ando et al., 2022).